XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash Flows from Operating Activities:    
Net income $ 82,885 $ 79,912
Amounts to reconcile net income to net cash flows provided by operating activities:    
Provision (benefit) for deferred income taxes 7,065 (129)
Depreciation and amortization 58,661 55,316
Amortization of deferred financing costs 2,841 2,567
Write-off of deferred financing costs 1,956 925
Stock-based compensation expense 3,929 3,213
Changes in:    
Trade receivables (22,074) (17,758)
Accounts payable and accrued liabilities (4,268) (11,390)
Other assets and liabilities 720 1,252
Net cash flows provided by operating activities 131,715 113,908
Cash Flows from Investing Activities:    
Purchases of property and equipment (95,353) (79,472)
Investment in Gaylord Rockies joint venture   (16,309)
Investment in other joint ventures (2,199) (1,969)
Purchase of remaining interest in Opry City Stage (3,948)  
Other investing activities (4,687) (3,654)
Net cash flows used in investing activities (106,187) (101,404)
Cash Flows from Financing Activities:    
Net borrowings (repayments) under revolving credit facility 80,500 (241,900)
Borrowings under term loan A   200,000
Borrowings under term loan B   500,000
Repayments under term loan B (1,250) (391,250)
Deferred financing costs paid (637) (12,220)
Payment of dividends (85,110) (79,788)
Payment of tax withholdings for share-based compensation (3,771) (3,769)
Other financing activities (10) 18
Net cash flows used in financing activities (10,278) (28,909)
Net change in cash, cash equivalents, and restricted cash 15,250 (16,405)
Cash, cash equivalents, and restricted cash, beginning of period 78,710 81,190
Cash, cash equivalents, and restricted cash, end of period 93,960 64,785
Reconciliation of cash, cash equivalents, and restricted cash to balance sheet:    
Cash and cash equivalents - unrestricted 61,779 49,610
Cash and cash equivalents - restricted 32,181 15,175
Cash, cash equivalents, and restricted cash, end of period $ 93,960 $ 64,785